EVENT OVERVIEW

This educational event is extremely timely considering that the pace of new cell & gene therapies continues to accelerate while cost management strategies are being developed in real-time. Given this reality, it is critical for those involved with self-insured group health plans to understand what is happening in the marketplace today and hear expert opinions on what to expect in the years ahead.

The carefully developed educational program will feature expert perspectives from the most important stakeholders, including cell & gene therapy manufacturers, providers, employers, patients, TPAs, brokers, captive consultants, stop-loss carriers, and reinsurers. Complimenting this prepared content, attendees will also have the opportunity to engage directly with each other as part of a dedicated open discussion session and multiple open networking times.